Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

APREMILAST vs ENSIFENTRINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

APREMILAST vs ENSIFENTRINE: Safety Overview

Metric APREMILAST ENSIFENTRINE
Total FAERS Reports 136,713 410
Deaths Reported 4,704 2
Death Rate 3.4% 0.5%
Hospitalizations 9,544 77
Average Patient Age 54.0 yrs 71.7 yrs
% Female Patients 67.3% 51.6%
FDA Approval Date Apr 7, 2023 Jun 26, 2024
Manufacturer Amgen, Inc Verona Pharma, Inc.
Route ORAL RESPIRATORY (INHALATION)
Marketing Status Prescription Prescription